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Abstract
NIPA (Nuclear Interaction Partner of Alk kinase) is an F-box like protein that targets nuclear Cyclin B1 for degradation.
Integrity and therefore activity of the SCF
NIPA E3 ligase is regulated by cell-cycle-dependent phosphorylation of NIPA,
restricting substrate ubiquitination to interphase. Here we show that phosphorylated NIPA is degraded in late mitosis in an
APC/C
Cdh1-dependent manner. Binding of the unphosphorylated form of NIPA to Skp1 interferes with binding to the APC/C-
adaptor protein Cdh1 and therefore protects unphosphorylated NIPA from degradation in interphase. Our data thus define
a novel mode of regulating APC/C-mediated ubiquitination.
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Introduction
Cell cycle transitions are regulated by the temporally controlled
activity of kinase cascades and ubiquitin-mediated proteolysis of key
regulatory proteins. Two types of E3 ligase complexes, the Cullin-
RING E3 ligases, including SCF (Skp1/Cullin/F-box protein)
complexes and anaphase promoting complex or cyclosome (APC/
C), are essential for regulating cell cycle progression [1,2].
Activation of the APC/C is dependent on mitosis-specific
phosphorylation of several subunits [3–6] and on the sequential
binding of the WD-repeat-containing proteins, Cdc20 and Cdh1
[7,8], which are thought to recruit substrates to the core enzyme.
Targeting of substrates by the APC/C depends on short
destruction motifs in their primary sequence. The most
commonly found sequences are the destruction-box (D-box,
RxxL) [9,10] and the KEN-box (KENxxxN) [11]. However,
recent reports have revealed several other motifs apart from these
canonical sites [12–15].
NIPA (nuclear interaction partner of ALK) was originally identified
by our group as a human nuclear protein in a screen for interaction
partners of the activated anaplastic lymphoma kinase (ALK) receptor
tyrosine kinase [16]. We subsequently characterized NIPA as an F-
box like protein that defines a ubiquitin E3 ligase (SCF
NIPA)w h i c h
targets nuclear cyclin B1 for degradation and thereby contributes to
the timing of mitotic entry. Intriguingly, phosphorylation of NIPA in
late G2 phase leads to dissociation of NIPA from the SCF core
complex, thus restricting activity of the SCF
NIPA complex to
interphase [17,18]. Here, we report that phosphorylated NIPA is
degraded at mitotic exit in an APC/C
Cdh1-dependent manner. This
degradation is regulated by the cell-cycle-dependent binding of NIPA
to the SCF core-protein Skp1 and represents a novel mode of
regulating APC/C-mediated ubiquitination.
Results
The phosphorylated form of NIPA is degraded in late
mitosis
Previous studies revealed phosphorylation of NIPA starting in
late G2 phase of the cell cycle and peaking at the G2/M boundary
(Fig. S1 and ref. [17]). After the G2/M transition, NIPA
phosphorylation and expression levels decline precipitously upon
entry into G1 and an unphosphorylated form of NIPA reappears
later in G1 (Fig. 1A, lanes 1–5). Treatment of the cells with the
translation inhibitor cycloheximide (CHX) after release from
prometaphase prevented accumulation of the non-phosphorylated
form of NIPA in G1 (Fig. 1A, lanes 6–10). This result indicates
that the appearance of the lower form of NIPA is due to new
protein synthesis rather than dephosphorylation of the upper form
of NIPA and thus suggests that the phosphorylated form of NIPA
is degraded in late mitosis. Remarkably, phosphorylated NIPA was
degraded simultaneously with Cdc20, Cyclin B1 and Cyclin A,
three known mitotic substrates of the APC/C (Fig. 1B).
To investigate whether NIPA degradation may be regulated by
ubiquitination, we tested whether NIPA is polyubiquitinated in
vivo. Therefore, cells were transfected with Flag-NIPA, HA-
ubiquitin or with both. The transfected cells were treated with
MG132 prior to harvesting. Immunoblotting detected high
molecular weight ubiquitin conjugates in the Flag-NIPA im-
muno-complex in the presence of MG132 (Fig. 1C). To
determine whether proteasomal function is required for NIPA
degradation, NIPA-overexpressing cells were treated with cyclo-
hexamide and the proteasome inhibitor MG132. Proteasome
inhibition resulted in significant stabilization of NIPA (Fig. 1D).
These results provide evidence that the ubiquitin-proteasome
pathway controls the destruction of NIPA.
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Since NIPA degradation occurs simultaneously with other APC/
C-targets, we examined whether APC/C is required for NIPA
degradation. To this end, we prepared extracts with high APC/C-
activity and depleted APC/C from the extracts with antibody
against Cdc27, a core subunit of APC/C, prior to in vitro
degradation assays. We observed that exogenous, not Skp1-bound
35S-labeled NIPA was destroyedintheextract with APC/C activity,
but was stabilized in the extract depleted by the Cdc27 antibody
(Fig. 2A, upper panel). Western blot analysis confirmed that Cdc27
was successfully removed from the extract (Fig. 2A, lower panel).
The APC activator proteins Cdc20 and Cdh1 directly bind to
their substrates to recruit them to the APC core complex [19–21].
To examine whether NIPA binds to one of these WD40 proteins in
vivo, we performed co-immunoprecipitation studies. We found that
NIPA binds to Cdh1 but not to Cdc20 (Fig. 2B, 2C and Fig. S2),
suggesting that Cdh1 may mediate APC/C-dependent degrada-
tion of NIPA. Importantly, we were not able to show binding of
NIPA and Cdh1 when only low expression of NIPA was observed
(data not shown; see discussion).
To test whether NIPA was a substrate of APC/C, we examined
whether immuno-purified APC/C directly catalyzed the ubiqui-
tination of NIPA in vitro. NIPA was ubiquitinated by the APC/C in
vitro and this ubiquitination was promoted by the addition of Cdh1
(Fig. 2D and 2E). The absence of the high-molecular weight forms
of NIPA in samples in which E1 ubiquitin-activating enzyme was
omitted from the reaction confirms that they present ubiquitin
conjugates of NIPA (Fig. 2F).
To examine whether APC/C
Cdh1 regulates NIPA stability in
vivo, we studied the kinetics of NIPA degradation after a decrease
of APC/C activity through knockdown of Cdh1. Hela cells were
transfected with small interfering RNA targeted to Cdh1 or a
control siRNA and arrested at prometaphase. Mitotic cells were
then released into fresh media and examined at various timepoints
thereafter. We observed that knockdown of Cdh1 resulted in a
significant stabilization of the phosphorylated form of endogenous
NIPA, indicating that APC/C
Cdh1 indeed promotes degradation
of NIPA at the exit of mitosis (Fig. 2G).
To further substantiate the role of Cdh1 in regulating the
degradation of NIPA in vivo, we overexpressed Cdh1 in cells stably
expressing a Flag-NIPA construct. Following transfection, cells
were synchronized by nocodazole treatment with a subsequent
release from the mitotic block. We found that overexpression of
Cdh1 clearly accelerated the degradation of NIPA during the
mitotic exit phase (Fig. 2H). This suggests that Cdh1 acts as a rate-
limiting factor for the degradation of phosphorylated NIPA.
Figure 1. Phosphorylated NIPA is degraded during mitotic exit. (A) NIH3T3 cells stably overexpressing Flag-NIPA were arrested in
prometaphase by a thymidine-nocodazole block and subsequently released into fresh medium either containing cycloheximide (CHX) or without
supplements. Cells were collected at the indicated timepoints. The degree of synchronization was confirmed by analysis of the expression of cyclin B1
and FACS analysis (data not shown). (B) HeLa cells were arrested in prometaphase, released into fresh growth medium, and harvested for Western
blot at the indicated timepoints. (C) HEK293T cells were transfected with (+) or without (-) HA-Ubiquitin and Flag-NIPA as indicated. Following
treatment with MG132, extracts were prepared, denatured and subjected to Flag immunoprecipitation. Ubn: polyubiquitinated forms. (D) NIH3T3
cells retrovirally infected with a Flag-NIPA construct were treated with cycloheximide (CHX) and either DMSO or the proteasome inhibitor MG132.
Cells were harvested for Western blot at the indicated timepoints.
doi:10.1371/journal.pone.0028998.g001
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Cdh1 mediates
degradation of NIPA in mitotic exit.
Identification of NIPA domains required for its
degradation
Previous studies revealed that the APC/C recognizes partic-
ular destruction motifs in its substrates. By sequence analysis, we
identified two putative D-box-like motifs in NIPA, whereof the
second motif is conserved throughout human, mouse and Xenopus
laevis (Fig. 3A,B). No other known putative Cdh1 recognition
motifs were further identified. Mutation of these two D-box-like
motifs leads to a decreased in vitro ubiquitination by the APC/
C
Cdh1 (Fig. 3C), indicating that these motifs are functional
degradation motifs. However, the D-box mutant was not
stabilized in vivo during mitotic exit (data not shown). The
second D-box motif partially overlaps with the nuclear
localization signal of NIPA and mutation of this putative
degradation motif leads to cytoplasmic relocalization of the
NIPA protein (Fig. S3), likely interfering with proper ubiquitina-
tion of NIPA.
In vitro binding assays identified amino acids 395–402 of NIPA
as the relevant Cdh1-binding site (Fig. S4). This region also
harbors the nuclear localization signal and the substrate binding
site for Cyclin B1 [16,18].
Figure 2. NIPA is degraded in an APC/C
Cdh1-dependent manner. (A) Autoradiogram of
35S-labelled NIPA after incubation in HeLa cell extract
prepared from G1 cells. Where indicated, the APC/C was depleted from the extract using a Cdc27 antibody. The Cdc27 Western blot shows efficient
removal of Cdc27 from extracts. (B) Flag-NIPA and either HA-Cdh1 or HA-Cdc20 were expressed in HEK293T cells, and MG132 was added 6 h before
the cells were collected. Cell extracts were immunoprecipitated (IP) with an antibody against Flag. (C) Flag-NIPA was expressed in HEK293T cells, and
MG132 was added 6 h before the cells were collected. Cell extracts were immunoprecipitated (IP) with an antibody against Flag. (D) Autoradiogram
of
35S-labelled NIPA after in vitro ubiquitination by APC/C immunoprecipitates derived from HeLa cells. Cdh1 was supplemented, where indicated.
Ubn: polyubiquitinated forms. (E) and (F) Flag-NIPA was transiently expressed in HEK293T cells and immunoprecipitated using an agarose-bound
anti-Flag antibody. Immunoprecipitates were used in APC in vitro ubiquitination reactions. Cdh1 and E1 ubiquitin-activating enzyme were
supplemented as indicated. (G) HeLa cells were transfected with either control (firefly Luciferase) siRNA or NIPA siRNA, synchronized in prometaphase
and subsequently released for the indicated times. (H) NIH3T3 cells stably overexpressing Flag-NIPA were transfected with empty vector or Cdh1,
synchronized in prometaphase and then released for the indicated periods of time.
doi:10.1371/journal.pone.0028998.g002
Figure 3. Degradation motifs in NIPA. (A) Schematic presentation of the NIPA protein, indicating the position of the D-box motifs. C:
carboxyterminus; C3HC: Zinc-Finger motif; N: aminoterminus; NLS: nuclear localization signal; S: serine residue. (B) Alignment of NIPA D-box-like
motifs in different species. C, Immunopurified APC/C supplemented with recombinant Cdh1 ubiquitinates wildtype NIPA in vitro but not the Dbox1+2
mutant.
doi:10.1371/journal.pone.0028998.g003
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Cdh1 complex is active from late anaphase until late
in G1. As unphosphorylated NIPA accumulates during this period
of the cell cycle, a mechanism should exist, which protects the
unphosphorylated form of NIPA from degradation, while
phosphorylated NIPA is readily targeted by the APC/C
Cdh1
complex. Since the phosphorylation status of NIPA regulates its
binding to the SCF core protein, we hypothesized that the binding
to Skp1 might control stability of NIPA. In accordance with this
hypothesis, a mutant of NIPA, which is impaired in its binding to
Skp1 by a mutation in the F-Box motif [17], has a significantly
reduced stability compared to the wildtype protein (Fig. 4A). This
reduced stability is associated with a more efficient ubiquitination
of this mutant in vivo (Fig. 4B).
We therefore next tested whether binding to Skp1 protects
NIPA from degradation in vitro. To this end, in vitro translated Flag-
NIPA was incubated with purified GST-Skp1 to allow binding
Figure 4. Binding to Skp1 protects NIPA from APC/C
Cdh1-mediated degradation. (A) HEK293T cells transfected with Flag-NIPA wt or the F-
Box mutant were treated with cycloheximide (CHX) for the indicated times and analyzed for total NIPA levels by immunoblotting. (B) HEK293T cells
were transfected with HA-Ubiquitin and different amounts of Flag-NIPA wt or F-Box mutant to balance their expression. Following treatment with
MG132, extracts were prepared, denatured and subjected to Flag immunoprecipitation. (C) Autoradiogram of an in vitro degradation assay using
HeLa cell extract prepared from G1 cells.
35S-labelled Flag-NIPA was incubated with GST-Skp1 or GST and subsequently immunoprecipitated with
agarose-bound anti-Flag antibody before being used in degradation assays. (D) Flag-NIPA was transiently expressed in HEK293T cells and
immunoprecipitated using an agarose-bound anti-Flag antibody. Immunoprecipitates were used in APC in vitro ubiquitination reactions. Cdh1 and
Skp1 were supplemented, where indicated. (E) HA-Cdh1 was co-expressed with Flag-NIPA and Skp1 in HEK293T cells as indicated. Cell extracts were
immunoprecipitated (IP) with an antibody against Flag and analysed by immunoblotting.
doi:10.1371/journal.pone.0028998.g004
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incubation with GST-Skp1 protects NIPA from degradation in G1-
synchronized cell extracts. Furthermore, addition of purified Skp1
to in vitro ubiquitylation reactions greatly reduced APC/C
Cdh1-
mediated in vitro ubiquitylation of NIPA (Fig. 4D). These results
suggest that binding to Skp1, rather than phosphorylation of NIPA
itself, regulates degradation of NIPA by the APC/C
Cdh1 complex.
To further define the mechanism by which Skp1 regulates
NIPA degradation, we investigated whether Skp1 and Cdh1
compete for binding with NIPA. To this end, we performed co-
immunoprecipitation assays of Flag-NIPA and HA-Cdh1 in cells
overexpressing Skp1 or not. As shown in Figure 4E, co-expression
of Skp1 inhibits binding of NIPA and Cdh1.
We thus conclude that binding of NIPA to Skp1 protects it from
APC/C
Cdh1-mediated degradation by interfering with the inter-
action of NIPA with Cdh1. Phosphorylation of NIPA, however,
leads to dissociation of NIPA from Skp1 and therefore allows
recognition of NIPA by the APC/C
Cdh1-complex and conse-
quently degradation of NIPA. This provides a mechanistic
explanation of how unphosphorylated NIPA is able to accumulate
during G1 phase of the cell cycle, while phosphorylated NIPA is
targeted by the APC/C
Cdh1-complex.
Discussion
At the G2/M transition, the NIPA F-box protein is phosphor-
ylated on several serine residues [18]. This phosphorylation leads
to dissociation of the SCF
NIPA E3 ligase. In late mitosis, the
phosphorylated form of NIPA disappears, while simultaneously a
nonphosphorylated form of NIPA emerges.
Here we show that the phosphorylated form of NIPA is
degraded by the ubiquitin-proteasome system in late mitosis. It has
been shown before that certain F-Box proteins are themselves
ubiquitinated and degraded. Initially, this was attributed to an
auto-ubiquitination reaction of the F-Box proteins [22]. However,
for the two F-Box proteins Skp2 and Tome-1 an SCF-
independent, but rather APC/C
Cdh1-dependent degradation was
shown recently [23–25]. Here, we further establish NIPA as a
target of the APC/C
Cdh1 in vitro and in vivo.
The APC/C
Cdh1 is active during the G1 phase. However,
unphosphorylated NIPA accumulates during this phase of the cell
cycle, indicating that the APC/C
Cdh1 exclusively ubiquitinates the
phosphorylated form of NIPA, while the unphosphorylated form is
protected from recognition by the APC/C
Cdh1.
This regulation of an APC/C substrate by phosphorylation is
remarkable since it was assumed until recently that APC/C-
mediated ubiquitination is regulated by the activity of the ligase
itself. Nevertheless, several reports recently showed a regulation of
APC/C-mediated ubiquitination by substrate modification (for
example see refs. 25–27). For NIPA we show however, that not
phosphorylation itself, but the phosphorylation-induced dissocia-
tion from the SCF core protein Skp1 targets NIPA for
degradation. In line with this model, mutation of the F-Box like
motif in NIPA, which abolishes its binding to Skp1, greatly reduces
the stability of the NIPA protein.
Wei et al. reported that a Skp2 F-box mutant that cannot form
SCF complexes is a better APC/C
Cdh1 substrate than wild-type
Skp2 in vivo [23]. Strikingly, APC/C
Cdh1-mediated ubiquitination
of Skp2, similarly to NIPA, is regulated by timely phosphorylation
of Skp2 [26]. However, it seems that this phosphorylation of Skp2
does not influence its binding to the SCF core complex [27,28],
therefore the cell-cycle dependent ubiquitination of Skp2 by the
APC/C does not appear to be regulated by its interaction with
Skp1. Nevertheless, APC/C-mediated ubiquitination of Skp2 and
other substrates might not be regulated by phosphorylation itself,
but rather by phosphorylation-induced modifications of interac-
tions which regulate APC/C-dependent ubiquitination as we have
shown here for NIPA.
Despite exclusive degradation of the phosphorylated form of
NIPA in late mitosis and G1, we were able to show APC/C
Cdh1-
dependent ubiquitination and degradation of the unphosphory-
lated form in vitro. This finding further supports the theory that
phosphorylation of NIPA itself has no impact on its availability for
the APC/C.
Similarly, we were able to observe ubiquitination of unpho-
sphorylated NIPA and its interaction with Cdh1 in vivo. However,
this was only possible if large amounts of NIPA were overex-
pressed, indicating that ubiquitination of unphosphorylated NIPA
can only take place if NIPA is present in excess compared to the
levels of Skp1. This finding further supports our theory that Skp1
protects NIPA from degradation by interfering with recruitment of
Cdh1.
We identified two putative destruction motifs in NIPA.
Mutation of these motifs leads to a decreased Cdh1-dependent
in vitro ubiquitination compared to the wildtype NIPA protein,
indicating a role of these motifs for Cdh1-dependent ubiquitina-
tion. However, we were not able to show a stabilization of the
mutant protein in vivo. This might be due to the fact that mutation
of the second D-box motif leads to cytoplasmic relocalization of
NIPA, likely interfering with proper ubiquitination of NIPA.
Nonetheless, further as yet unidentified degradation motifs might
be important for efficient degradation of NIPA in vivo.
In summary, our results provide evidence that the F-Box like
protein NIPA is degraded in late mitosis in an APC/C
Cdh1-
dependent manner. We further show that binding to the SCF core
complex protects NIPA from APC/C-mediated degradation,
leading to exclusive degradation of the phosphorylated form of
NIPA. We thus define a novel mode of controlling degradation of
F-Box proteins, providing an additional layer of control over
APC/C-mediated ubiquitination.
Materials and Methods
Plasmids, Antibodies and immunological procedures
Details of the construction of various NIPA plasmids are
available from the authors upon request. Point mutations of the
NIPA cDNA and deletion mutants were prepared using the
Quickchange mutagenesis kit (Stratagene). HA-tagged Cdh1 and
Cdc20 plasmids were kindly provided by M. Pagano and
pcDNA3.1-Skp1 was provieded by Z–Q. Pan. pCMV-HA-
Ubiquitin was a generous gift provided by W. Krek.
Anti-CDH1 antibody (Ab-2) was from Calbiochem and anti-
Skp1 antibody was from Zymed. Anti-Flag and anti-b-Actin
antibodies were from Sigma-Aldrich. Anti-CDC20 (H175), anti-
CDC27 (AF3.1), anti-Cyclin A (H-432), anti-Cyclin B1 (H-433),
anti-HA (Y-11) antibodies were from Santa Cruz. Anti-NIPA
antibody was described before [17]. Immunoblot analysis and
immunoprecipitations were performed as described [29].
Cell Culture, Synchronization, Transfection and
Treatment with Drugs
HeLa, NIH3T3 and HEK293T cells were cultivated in DMEM
supplemented with 10% FCS and 2 mM L-glutamine. Transient
transfections were performed using Lipofectamine 2000 (Invitro-
gen) transfection reagents. Stable NIH 3T3 cell lines have been
described before [17]. Cells were synchronized in prometaphase
by sequential culture with 2 mM thymidine for 12 h and 500 ng/
ml nocodazole for 10–12 h.
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of 50 mg/ml cycloheximide and to inhibit proteasomal degrada-
tion, cells were cultured in the presence of 10 mM MG132.
siRNA
siRNAs were purchased from Proligo and transfected into
subconfluent HeLa cells using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. The target sequence
of Cdh1 siRNA was 59-AATGAGAAGTCTCCCAGTCAG-39
[30]. A firefly luciferase siRNA served as control.
GST-fusion proteins and pull-down assays
Skp1, NIPA wt and all NIPA deletion mutants were expressed
in E.coli (BL-21) using pGEX vectors (Amersham) and purified on
Glutathion-S-Sepharose 4B beads (Amersham Pharmacia Bio-
tech). If required, purified proteins were eluted with 20 mM
glutathione in 100 mM Tris/HCl, pH 8.0, 120 mM NaCl.
For GST pull-down assays, 30 mlo fin vitro translated,
35S-labeled
Cdh1 was incubated with glutathione beads containing bound
NIPA wt, NIPA deletion mutants or GST alone in binding buffer
(10 mM Tris/HCl, pH 7.5, 100 mM NaCl, 5 mM EDTA, 0.1%
Triton X-100, protease inhibitor cocktail) for 1 h at 4uC. Bound
fractions were analyzed by SDS-PAGE prior to autoradiography.
In vivo ubiquitination
For detection of in vivo ubiquitin-conjugates of ectopic NIPA,
HEK293T cells were cotransfected with HA-tagged Ubiquitin and
Flag-NIPA constructs. Cells were treated with either MG132 or
DMSO 6 h before harvesting. Cell lysates were supplemented with
denaturation buffer (1 mM DTT, 50 mM Tris-Cl (pH 7.5),
0.5 mM EDTA, 1% SDS final concentration) and denatured for
10 min at 95uC prior to immunoprecipitation with agarose-bound
anti Flag antibody.
In vitro ubiquitination assays
The APC/C was purified from exponentially growing HeLa cells
as described before [31].
35S-labeled NIPA was prepared by in vitro
translation using a rabbit reticulocyte lysate (TNT, Promega). The
labeled substrate was addedtothe invitro ubiquitinationreactionmix
containing 40 mM Tris-Cl pH 7.6, 0.7 mM DTT, 5 mM MgCl2,
1 mg/ml ubiquitin, 10 mg/ml ubiquitin aldehyde, 0.84 mg/ml E1
ubiquitin-activating enzyme, 10 mg/ml UbcH10, 0.1 mg/ mlc y c l o -
heximide an ATP-generating system and APC/C-loaded beads. If
indicated, baculovirus-produced Cdh1 was added to the reaction.
The reaction was incubated at 30uC and fractions were taken at
indicated timepoints and diluted in SDS-sample buffer. The
ubiquitinated forms of NIPA were analyzed by SDS-PAGE prior
to autoradiography.
In vitro degradation assays
Early G1 synchronized HeLa cells were harvested and the cell
pellet was resuspended in lysis buffer (10 mM Tris-Cl, pH 7.5,
130 mM NaCl, 5 mM EDTA, 0,5%, Triton X-100, 20 mM
Na2HPO4/NaH2PO4 (pH 7.5), 10 mM sodiumpyrophosphate
(pH 7.0), 1 mM sodiumorthovanadate, 20 mM sodium-fluoride,
1 mM glycerol-2-phosphate and a protease inhibitor cocktail
(Complete; Roche)).
For degradation assays, the clarified supernatant was supple-
mented with 1.5 mg/ml ubiquitin, 0.1 mg/ml cycloheximide,
20 mM DTT, 1 mM MgCl2 and an energy mix. 36 microliters of
the extract was then added to four microliter of
35S-labeled
substrate synthesized by in vitro translation (Promega). Reactions
proceeded at 30uC for the indicated times, and the extent of
degradation was determined by autoradiography.
In the immunodepletion assay, anti-Cdc27 or preimmuneserum
and protein G beads were added to the extract for 2 h at 4uC. The
beads were removed by centrifugation, and the supernatant was
used for degradation assays. A portion of the extract was processed
for Western blot analysis.
Supporting Information
Figure S1 NIPA is phosphorylated in mitosis. Hela cells
were synchronized in prometaphase by a sequential thymidine-
nocodazole block. Cell extracts were either treated with acid
potato phosphatase or left untreated and analyzed by immuno-
blotting using an anti-NIPA antibody.
(TIF)
Figure S2 NIPA interacts with Cdh1. Myc-NIPA and either
HA-Cdh1 or HA-Cdc20 were expressed in HEK293T cells, and
MG132 was added 6 h before the cells were collected. Cell
extracts were immunoprecipitated (IP) with an antibody against
HA-tag and analysed by immunoblotting.
(TIF)
Figure S3 The Dbox-like motifs in NIPA. (A) Overlap of
the NLS and the Dbox2 motif in NIPA; amino acids 390–409 of
the NIPA protein are shown. (B) Mutation of the Dbox2 motif
interferes with correct nuclear localization of NIPA. Immunoflu-
orescence of NIH/3T3 cells expressing Flag-tagged NIPA
constructs.
(TIF)
Figure S4 Mapping of the Cdh1-binding site in NIPA. (A)
schematic presentation of the NIPA deletion mutants assayed in
(B). Binding of Cdh1 is indicated as +: binding similar to NIPAwt;
-: no significant binding. C3HC: Zinc-finger motif; NLS: nuclear
localization signal. (B) GST pulldown assays using various GST-
NIPA deletion constructs and
35S-labelled, in vitro translated Cdh1.
(TIF)
Acknowledgments
We thank M. Pagano for the Cdh1 and Cdc20 cDNA. W. Krek provided
the pCMV-HA-ubiquitin construct and Z–Q. Pan kindly provided the
Skp1 cDNA.
Author Contributions
Conceived and designed the experiments: CvK JD. Performed the
experiments: CvK FB AF SW RH. Analyzed the data: CvK FB ALI CP
JD. Wrote the paper: CvK JD.
References
1. Skaar JR, Pagano M (2009) Control of cell growth by the SCF and APC/C
ubiquitin ligases. Curr Opin Cell Biol 21: 816–824.
2. Sumara I, Maerki S, Peter M (2008) E3 ubiquitin ligases and mitosis: embracing
the complexity. Trends Cell Biol 18: 84–94.
3. Kraft C, Herzog F, Gieffers C, Mechtler K, Hagting A, et al. (2003) Mitotic
regulation of the human anaphase-promoting complex by phosphorylation.
Embo J 22: 6598–6609.
4. Golan A, Yudkovsky Y, Hershko A (2002) The cyclin-ubiquitin ligase activity of
cyclosome/APC is jointly activated by protein kinases Cdk1-cyclin B and Plk.
J Biol Chem 277: 15552–15557.
5. Rudner AD, Murray AW (2000) Phosphorylation by Cdc28 activates the Cdc20-
dependentactivityoftheanaphase-promotingcomplex.JCell Biol149:1377–1390.
6. Kotani S, Tanaka H, Yasuda H, Todokoro K (1999) Regulation of APC activity
by phosphorylation and regulatory factors. J Cell Biol 146: 791–800.
Skp1 Protects NIPA from APC/C-Mediated Degradation
PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e289987. Visintin R, Prinz S, Amon A (1997) CDC20 and CDH1: a family of substrate-
specific activators of APC-dependent proteolysis. Science 278: 460–463.
8. Schwab M, Lutum AS, Seufert W (1997) Yeast Hct1 is a regulator of Clb2 cyclin
proteolysis. Cell 90: 683–693.
9. Glotzer M, Murray AW, Kirschner MW (1991) Cyclin is degraded by the
ubiquitin pathway. Nature 349: 132–138.
10. King RW, Glotzer M, Kirschner MW (1996) Mutagenic analysis of the
destruction signal of mitotic cyclins and structural characterization of
ubiquitinated intermediates. Mol Biol Cell 7: 1343–1357.
11. Pfleger CM, Kirschner MW (2000) The KEN box: an APC recognition signal
distinct from the D box targeted by Cdh1. Genes Dev 14: 655–665.
12. Crane R, Kloepfer A, Ruderman JV (2004) Requirements for the destruction of
human Aurora-A. J Cell Sci 117: 5975–5983.
13. Reis A, Levasseur M, Chang HY, Elliott DJ, Jones KT (2006) The CRY box: a
second APCcdh1-dependent degron in mammalian cdc20. EMBO Rep 7:
1040–1045.
14. Araki M, Yu H, Asano M (2005) A novel motif governs APC-dependent
degradation of Drosophila ORC1 in vivo. Genes Dev 19: 2458–2465.
15. Bassermann F, Frescas D, Guardavaccaro D, Busino L, Peschiaroli A, et al.
(2008) The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response
checkpoint. Cell 134: 256–267.
16. Ouyang T, Bai RY, Bassermann F, von Klitzing C, Klumpen S, et al. (2003)
Identification and characterization of a nuclear interacting partner of anaplastic
lymphoma kinase (NIPA). J Biol Chem 278: 30028–30036.
17. Bassermann F, von Klitzing C, Munch S, Bai RY, Kawaguchi H, et al. (2005)
NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry.
Cell 122: 45–57.
18. Bassermann F, von Klitzing C, Illert AL, Munch S, Morris SW, et al. (2007)
Multisite phosphorylation of nuclear interaction partner of ALK (NIPA) at G2/
M involves cyclin B1/Cdk1. J Biol Chem 282: 15965–15972.
19. Sorensen CS, Lukas C, Kramer ER, Peters JM, Bartek J, et al. (2001) A
conserved cyclin-binding domain determines functional interplay between
anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle
progression. Mol Cell Biol 21: 3692–3703.
20. Schwab M, Neutzner M, Mocker D, Seufert W (2001) Yeast Hct1 recognizes the
mitotic cyclin Clb2 and other substrates of the ubiquitin ligase APC. Embo J 20:
5165–5175.
21. Hilioti Z, Chung YS, Mochizuki Y, Hardy CF, Cohen-Fix O (2001) The
anaphase inhibitor Pds1 binds to the APC/C-associated protein Cdc20 in a
destruction box-dependent manner. Curr Biol 11: 1347–1352.
22. Zhou P, Howley PM (1998) Ubiquitination and degradation of the substrate
recognition subunits of SCF ubiquitin-protein ligases. Mol Cell 2: 571–580.
23. Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, et al. (2004) Degradation
of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting
complex. Nature 428: 194–198.
24. Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M (2004)
Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin
ligase. Nature 428: 190–193.
25. Ayad NG, Rankin S, Murakami M, Jebanathirajah J, Gygi S, et al. (2003)
Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC. Cell 113:
101–113.
26. Rodier G, Coulombe P, Tanguay PL, Boutonnet C, Meloche S (2008)
Phosphorylation of Skp2 regulated by CDK2 and Cdc14B protects it from
degradation by APC(Cdh1) in G1 phase. Embo J 27: 679–691.
27. Bashir T, Pagan JK, Busino L, Pagano M (2010) Phosphorylation of Ser72 is
dispensable for Skp2 assembly into an active SCF ubiquitin ligase and its
subcellular localization. Cell Cycle 9: 971–974.
28. Boutonnet C, Tanguay PL, Julien C, Rodier G, Coulombe P, et al. (2010)
Phosphorylation of Ser72 does not regulate the ubiquitin ligase activity and
subcellular localization of Skp2. Cell Cycle 9: 975–979.
29. Duyster J, Baskaran R, Wang JY (1995) Src homology 2 domain as a specificity
determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA
polymerase II carboxyl-terminal repeated domain. Proc Natl Acad Sci U S A 92:
1555–1559.
30. Donzelli M, Squatrito M, Ganoth D, Hershko A, Pagano M, et al. (2002) Dual
mode of degradation of Cdc25 A phosphatase. Embo J 21: 4875–4884.
31. Amador V, Ge S, Santamaria PG, Guardavaccaro D, Pagano M (2007) APC/
C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase.
Mol Cell 27: 462–473.
Skp1 Protects NIPA from APC/C-Mediated Degradation
PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e28998